Page last updated: 2024-10-21

1-(1,3-benzodioxol-5-ylcarbonyl)piperidine and Fatigue

1-(1,3-benzodioxol-5-ylcarbonyl)piperidine has been researched along with Fatigue in 2 studies

1-(1,3-benzodioxol-5-ylcarbonyl)piperidine: crosses the blood brain barrier & enhances synaptic responses in freely moving animals

Fatigue: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fan, W1
Wu, X1
Pan, Y1
Li, C1
Niu, Y1
Zhai, Y1
Mei, Q1
Fan, WT1
Wu, XL1
Pan, YL1
Niu, YB1
Li, CR1
Mei, QB1

Other Studies

2 other studies available for 1-(1,3-benzodioxol-5-ylcarbonyl)piperidine and Fatigue

ArticleYear
1-(1,3-Benzodioxol-5-yl-carbo-nyl) piperidine, a modulator of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor, ameliorates exercise-induced fatigue in mice.
    Biological & pharmaceutical bulletin, 2014, Volume: 37, Issue:1

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antioxidants; Blood Urea Nitrogen

2014
[Synthesis and antifatigue activities of new benzamide derivatives].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2014, Volume: 49, Issue:10

    Topics: Animals; Benzamides; Dioxoles; Fatigue; Piperidines; Radioligand Assay; Receptors, AMPA; Swimming

2014